Location History:
- Norristown, PA (US) (1999 - 2000)
- Erdenheim, PA (US) (1999 - 2002)
- Edenheim, PA (US) (1999 - 2002)
Company Filing History:
10 out of 2,198 Years Active: 1999-2002
Title: Caretha Lee Creasy: Innovator in Protein Kinase Research
Introduction
Caretha Lee Creasy is a prominent inventor based in Erdenheim, PA (US). She has made significant contributions to the field of biotechnology, particularly in the area of human protein kinases. With a total of 9 patents to her name, her work has implications for therapeutic and diagnostic applications.
Latest Patents
One of her latest patents involves the Human protein kinase H2LAU20. This patent discloses the H2LAU20 polypeptides and polynucleotides, along with methods for producing these polypeptides through recombinant techniques. Additionally, it outlines methods for utilizing H2LAU20 polypeptides and polynucleotides in therapy and diagnostic assays. Another significant patent focuses on Rattus YAK1 polypeptides and polynucleotides, detailing methods for producing these polypeptides and screening for compounds that either agonize or antagonize Rattus YAK1. These compounds are expected to be beneficial in treating human diseases, including osteoarthritis, osteoporosis, and rheumatoid arthritis.
Career Highlights
Caretha is currently associated with SmithKline Beecham Corporation, where she continues her innovative work in biotechnology. Her research has not only advanced scientific understanding but also opened new avenues for medical treatments.
Collaborations
Throughout her career, Caretha has collaborated with notable colleagues, including Damien J. Dunnington and George P. Livi. These partnerships have further enriched her research and contributed to her success as an inventor.
Conclusion
Caretha Lee Creasy stands out as a leading figure in the field of protein kinase research. Her innovative patents and contributions to biotechnology have the potential to impact various therapeutic areas significantly.